Protein tyrosine kinase p56lck-deficiency confers hypersusceptibility to rho-fluorophenylalanine (pFPhe)-induced apoptosis by augmenting mitochondrial apoptotic pathway in human Jurkat T cells

Biochem Biophys Res Commun. 2008 Dec 5;377(1):280-5. doi: 10.1016/j.bbrc.2008.09.126. Epub 2008 Oct 7.

Abstract

Phenylalanine analog, rho-fluorophenylalanine (pFPhe)-mediated cytotoxicity and several apoptotic events including mitochondrial cytochrome c release, activation of caspase-9, -3, and -8, Bid cleavage, degradation of PARP and PLCgamma-1, and DNA fragmentation were more significant in p56(lck)-deficient Jurkat T cells (JCaM1.6) than in wild-type Jurkat T cells (E6.1). The susceptibility of JCaM1.6 toward apoptogenic activity of pFPhe decreased after acquisition of p56(lck) by transfection. The p56(lck) kinase activity increased 1.6-fold at 15-30 min after pFPhe treatment. The pan-caspase inhibitor (z-VAD-fmk) completely blocked the pFPhe-mediated apoptotic changes except caspase-9 activation. The caspase-8 inhibitor (z-IETD-fmk), which failed to influence pFPhe-induced caspase-9 activation, completely blocked caspase-8 activation and PLCgamma-1 degradation with a marked reduction in caspase-3 activation and PARP degradation, indicating pFPhe-induced caspase-8 activation as a downstream event of mitochondria-dependent activation of caspase-9. These results indicate that the deficiency of p56(lck) augments pFPhe-induced mitochondrial cytochrome c release and resultant apoptotic cell death in Jurkat T cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics*
  • Caspase Inhibitors
  • Caspases / metabolism
  • Cysteine Proteinase Inhibitors / pharmacology
  • Cytochromes c / metabolism*
  • Drug Resistance / genetics*
  • Humans
  • Jurkat Cells
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / genetics*
  • Mitochondria / drug effects*
  • Mitochondria / enzymology
  • Oligopeptides / pharmacology
  • Phospholipase C gamma / antagonists & inhibitors
  • Phospholipase C gamma / metabolism
  • p-Fluorophenylalanine / pharmacology*

Substances

  • Caspase Inhibitors
  • Cysteine Proteinase Inhibitors
  • Oligopeptides
  • benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone
  • p-Fluorophenylalanine
  • Cytochromes c
  • Lymphocyte Specific Protein Tyrosine Kinase p56(lck)
  • Phospholipase C gamma
  • Caspases